Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria

被引：0
|
作者：
Amol T. Kothekar
Jigeeshu Vasishtha Divatia
Sheila Nainan Myatra
Anand Patil
Manjunath Nookala Krishnamurthy
Harish Mallapura Maheshwarappa
Suhail Sarwar Siddiqui
Murari Gurjar
Sanjay Biswas
Vikram Gota
机构：
[1] Tata Memorial Centre,Department of Anesthesiology, Critical Care and Pain
[2] Homi Bhabha National Institute,Department of Anesthesiology, Critical Care and Pain
[3] Tata Memorial Hospital,Department of Clinical Pharmacology
[4] Homi Bhabha National Institute,Department of Critical Care Medicine
[5] Advanced Centre for Treatment,Department of Critical Care Medicine
[6] Research and Education in Cancer (ACTREC),Department of Microbiology
[7] Tata Memorial Centre,undefined
[8] Homi Bhabha National Institute,undefined
[9] Mazumdar Shaw Medical Centre,undefined
[10] Narayana Health,undefined
[11] King George’s Medical University,undefined
[12] Tata Memorial Hospital,undefined
[13] Homi Bhabha National Institute,undefined
来源：
Annals of Intensive Care | / 10卷
关键词：
Meropenem dosing; Anti-bacterial agents; Antimicrobial pharmacokinetics; Septic shock;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 17 条
  • [1] Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria
    Kothekar, Amol T.
    Divatia, Jigeeshu Vasishtha
    Myatra, Sheila Nainan
    Patil, Anand
    Nookala Krishnamurthy, Manjunath
    Maheshwarappa, Harish Mallapura
    Siddiqui, Suhail Sarwar
    Gurjar, Murari
    Biswas, Sanjay
    Gota, Vikram
    ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [2] Clinical and Demographic Factors Associated with Antipyretic Use in Gram-Negative Severe Sepsis and Septic Shock
    Mohr, Nicholas M.
    Fuller, Brian M.
    Skrupky, Lee P.
    Moy, Hawnwan
    Alunday, Robert
    Micek, Scott T.
    Fagley, Richard E.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1207 - 1216
  • [3] Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia
    Kang, Cheol-In
    Song, Jae-Hoon
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Ko, Kwan Soo
    Yeom, Joon-Sup
    Ki, Hyun Kyun
    Son, Jun Seong
    Lee, Seung Soon
    Kim, Yeon-Sook
    Jung, Sook-In
    Kim, Shin-Woo
    Chang, Hyun-Ha
    Ryu, Seong Yeol
    Kwon, Ki Tae
    Lee, Hyuck
    Moon, Chisook
    JOURNAL OF INFECTION, 2011, 62 (01) : 26 - 33
  • [4] IMMUNOLOGICAL AND CLINICAL EFFECTS OF MYCOBACTERIUM W IN PATIENTS WITH SEVERE GRAM NEGATIVE SEPSIS/SEPTIC SHOCK
    GuruMurthy, G.
    Jain, S.
    Dhawan, V.
    SHOCK, 2011, 35 : 22 - 23
  • [5] Nested-PCR as a tool for the detection and differentiation of Gram-positive and Gram-negative bacteria in patients with sepsis-septic shock
    Lozano Zarain, Patricia
    Lopez-Tellez, Genaro
    del Carmen Rocha-Gracia, Rosa
    Romero-Lopez, Cuauhtemoc
    Martinez-Laguna, Ygnacio
    Rivera, Antonio
    Brambila, Eduardo
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (21): : 4601 - 4607
  • [6] Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: Dosing considerations
    Kondo, Naru
    Ikawa, Kazuro
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Ohge, Hiroki
    Morikawa, Norifumi
    Sueda, Taijiro
    PANCREATOLOGY, 2014, 14 (02) : 95 - 99
  • [7] Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
    Marya D Zilberberg
    Andrew F Shorr
    Scott T Micek
    Cristina Vazquez-Guillamet
    Marin H Kollef
    Critical Care, 18
  • [8] Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
    Zilberberg, Marya D.
    Shorr, Andrew F.
    Micek, Scott T.
    Vazquez-Guillamet, Cristina
    Kollef, Marin H.
    CRITICAL CARE, 2014, 18 (06)
  • [9] Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
    Pea, Federico
    Viale, Pierluigi
    Cojutti, Piergiorgio
    Furlanut, Mario
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (12) : 6343 - 6348
  • [10] Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
    Troisi, Carla
    Cojutti, Pier Giorgio
    Rinaldi, Matteo
    Laici, Cristiana
    Siniscalchi, Antonio
    Viale, Pierluigi
    Pea, Federico
    PHARMACEUTICS, 2023, 15 (02)
12